Efficacy and Safety of Switching to Dolutegravir/Lamivudine (DTG/3TC) in Treatment-Experienced, Virologically Suppressed PLHIV Aged >= 50 Years: Pooled Results From the TANGO and SALSA Studies

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY(2022)

引用 0|浏览13
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要